| Authors: |
Oberst S; Organisation of European Cancer Institutes, Cancer Research UK Cambridge Centre, Cambridge CB2 0RE, UK. Electronic address: simon.oberst@cruk.cam.ac.uk., van Harten W; The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands; Rijnstate Hospital, Arnhem, Netherlands., Sæter G; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., de Paoli P; Alliance Against Cancer, Rome, Italy., Nagy P; National Institute of Oncology, Budapest, Hungary., Burrion JB; Institut Jules Bordet, Brussels, Belgium., Lovey J; National Institute of Oncology, Budapest, Hungary., Philip T; Organisation of European Cancer Institutes, Institut Curie, Paris, France. |